Evaluation of 4 weeks' neonatal antiretroviral prophylaxis as a component of a prevention of mother-to-child transmission program in a resource-rich setting.
AffiliationDepartment of Pediatric Infectious Diseases, Our Lady's Children's Hospital, Dublin, Ireland. firstname.lastname@example.org
Infectious Disease Transmission, Vertical
Polymerase Chain Reaction
Pregnancy Complications, Infectious
MetadataShow full item record
CitationEvaluation of 4 weeks' neonatal antiretroviral prophylaxis as a component of a prevention of mother-to-child transmission program in a resource-rich setting. 2011, 30 (5):408-12 Pediatr. Infect. Dis. J.
JournalThe Pediatric infectious disease journal
AbstractThis study provides evidence to support the current clinical practice toward use of a 4-week neonatal ARV prophylaxis regimen.
- Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting.
- Authors: Shah M, Johns B, Abimiku A, Walker DG
- Issue date: 2011 May 15
- Raltegravir in pregnancy: a case series presentation.
- Authors: Taylor N, Touzeau V, Geit M, Gisinger M, Egle A, Greil R, Rieger A, Zangerle R
- Issue date: 2011 Jun
- Advances in the prevention of vertical transmission of human immunodeficiency virus.
- Authors: Mofenson LM
- Issue date: 2003 Oct
- International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
- Authors: Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N
- Issue date: 2007 Sep
- Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
- Authors: Kesho Bora Study Group.
- Issue date: 2011 Jan